An update from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) is now available.
Jubilant Pharmova Limited announced that the allegations against its Chairman, Mr. Shyam S. Bhartia, have been dismissed as baseless by the authorities, with a court order accepting the closure report. The company emphasized that the case had no material impact on its operations, maintaining its stability and market position.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality in the healthcare sector.
YTD Price Performance: -14.95%
Average Trading Volume: 13,848
Current Market Cap: 146.4B INR
Find detailed analytics on JUBLPHARMA stock on TipRanks’ Stock Analysis page.